Alector Inc (ALEC)
3.76
+0.12
(+3.44%)
USD |
NASDAQ |
Nov 21, 16:00
3.76
0.00 (0.00%)
After-Hours: 20:00
Alector Enterprise Value: -88.98M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -88.98M |
| November 20, 2024 | -101.22M |
| November 19, 2024 | -80.16M |
| November 18, 2024 | -88.98M |
| November 15, 2024 | -59.11M |
| November 14, 2024 | 23.65M |
| November 13, 2024 | 44.70M |
| November 12, 2024 | 86.32M |
| November 11, 2024 | 136.27M |
| November 08, 2024 | 105.91M |
| November 07, 2024 | 95.14M |
| November 06, 2024 | 55.96M |
| November 05, 2024 | 31.97M |
| November 04, 2024 | 58.90M |
| November 01, 2024 | 34.42M |
| October 31, 2024 | 24.61M |
| October 30, 2024 | 42.24M |
| October 29, 2024 | 39.30M |
| October 28, 2024 | 39.30M |
| October 25, 2024 | 8.944M |
| October 24, 2024 | -6.724M |
| October 23, 2024 | 0.1306M |
| October 22, 2024 | 3.068M |
| October 21, 2024 | -5.745M |
| October 18, 2024 | 31.47M |
| Date | Value |
|---|---|
| October 17, 2024 | 47.14M |
| October 16, 2024 | 52.03M |
| October 15, 2024 | 39.30M |
| October 14, 2024 | 22.65M |
| October 11, 2024 | 12.86M |
| October 10, 2024 | -11.62M |
| October 09, 2024 | 26.57M |
| October 08, 2024 | -3.787M |
| October 07, 2024 | -14.56M |
| October 04, 2024 | -4.766M |
| October 03, 2024 | -43.94M |
| October 02, 2024 | -16.52M |
| October 01, 2024 | -11.62M |
| September 30, 2024 | -0.8487M |
| September 27, 2024 | -24.51M |
| September 26, 2024 | -35.22M |
| September 25, 2024 | -23.54M |
| September 24, 2024 | 2.736M |
| September 23, 2024 | 27.07M |
| September 20, 2024 | 56.26M |
| September 19, 2024 | 94.22M |
| September 18, 2024 | 45.56M |
| September 17, 2024 | 45.56M |
| September 16, 2024 | 49.45M |
| September 13, 2024 | 83.51M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-271.67M
Minimum
Nov 13 2023
2.840B
Maximum
Jul 07 2021
515.08M
Average
128.48M
Median
Dec 31 2023
Enterprise Value Benchmarks
| Precision BioSciences Inc | -29.06M |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
| iBio Inc | 12.31M |
| Theriva Biologics Inc | -12.68M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -42.22M |
| Revenue (Quarterly) | 15.34M |
| Total Expenses (Quarterly) | 63.78M |
| EPS Diluted (Quarterly) | -0.43 |
| Profit Margin (Quarterly) | -275.2% |
| Earnings Yield | -45.21% |
| Normalized Earnings Yield | -45.21 |